Log In
Wednesday 14th November 2018

Prostate trial 'promising'

17th April 2012

A study involving 41 patients published in the Lancet Oncology journal has suggested that using targeted ultrasound on prostate cancer patients could have fewer side effects than existing treatments.

Hashim Ahmed, a urological surgeon at the trust who headed the research, which was funded by the Medical Research Council, said: "We've shown in this study that focal therapy - by targeting the individual areas of cancer - can avoid the collateral damage. We've shown that nine in 10 men had no impotence and none of the men in the study had incontinence of urine."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018